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 probes highly reliable in over 150 cases [emphasis mine]
of breast reconstruction” by citing their Journal of Plastic,
Reconstructive & Aesthetic Surgery article. However, the
Journal of Plastic, Reconstructive & Aesthetic Surgery article
only had 121 flaps in 103 patients.
The Journal of Plastic, Reconstructive & Aesthetic Surgery
article reported a false-positive rate of 6.7 percent. The
authors should have apprised Plastic and Reconstructive
Surgery readers of this fact rather than writing that there
were “no complications from the probe.” With the Plas-
tic and Reconstructive Surgery cohort having only 10 flaps
in eight patients, I would not have expected there to
have been any false-positive results. A false-positive
reading is a complication, particularly if it leads to an
unnecessary return to surgery.
I also noted that the Journal of Plastic, Reconstructive&
Aesthetic Surgery article disclosed that “Cook awarded a
Microsurgery Traveling Fellowship to Mr. Iain S. Whi-
taker to support his work with Dr. Rafael Acosta in
Uppsala.” However, this fact was not disclosed in the
Plastic and Reconstructive Surgery article. As your distin-
guished predecessor, the late Robert Goldwyn, wrote
about financial disclosure:
“The reason for this rule is to permit the reader [em-
phasis mine] to assess the possible value of an article
written by an author or authors who might benefit from
its publication.”3 Without disclosure, we readers cannot
make this assessment.
As Dr. Acosta was the corresponding author for both
articles, I believe that we readers are entitled to know
the following:
1. How many of the 121 reconstructions reported in
the Journal of Plastic, Reconstructive & Aesthetic Sur-
gery used buried flaps?
2. In Plastic and Reconstructive Surgery, you claimed
that “over 150 cases” had been performed, citing
your Journal of Plastic, Reconstructive & Aesthetic
Surgery article. How do you explain the greater
than 30-flap discrepancy between the 121 flaps in
the Journal of Plastic, Reconstructive & Aesthetic Sur-
gery article compared with the “over 150” flaps
you cite as having been studied in the Journal of
Plastic, Reconstructive & Aesthetic Surgery article?
That is greater than a 25 percent discrepancy in
the number of flaps reported.
3. With a 6.7 percent false-positive rate, how do you
manage your abnormal probe signals in buried
flaps, as you cannot rely on observing a skin
island as you did in case 15 of your Journal of
Plastic, Reconstructive & Aesthetic Surgery article?
Do you take all of your patients with abnormal
probe signals and buried flaps back to surgery?
4. Did Dr. Whitaker receive a fellowship from Cook
Medical, Inc. (Bloomington, Ind.) for his studies
that included this article?
5. Are there any other financial disclosures or other
competing interests that you previously did not
disclose?
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Reply
Sir:
Thank you for the opportunity to reply to the letter by
Dr. Freshwater. Dr. Freshwater has asked some questions
regarding our recent report in the April of 2010 issue of
Plastic and Reconstructive Surgery in which we present a
unique series of buried deep inferior epigastric perforator
flaps for breast reconstruction in which there was no
cutaneous paddle for flap monitoring,1 a technique that
can be achieved safely only with the use of a technique for
flap monitoring such as the implantable Doppler probe.
No similar series of buried deep inferior epigastric per-
forator flaps for breast reconstruction has been previously
published to our knowledge. Dr. Freshwater has written
to us previously, echoing the suggestion made here that
some of our data may be misleading or duplicated—this
ignores the fact that this article underwent extensive peer
review by multiple reviewers, including a biostatistician, as
did the Journal of Plastic, Reconstructive & Aesthetic Surgery
article he mentions.
The first question raised pertains to a reference to
some of our other experience with the implantable Dopp-
ler probe. This reference was suitably made to demon-
strate our broader experience with breast reconstruction
and with the implantable Doppler probe, and to allow
readers to identify any perceived connections between the
works. This was not to highlight our only experience. The
use of appropriate referencing and specific titles in
the two articles clearly demonstrates this.
The letter by Dr. Freshwater also brings up some
fallacies that are often entertained about the use of new
or advanced techniques for postoperative flap monitor-
ing. Each technique for flap monitoring has an intrinsic
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rate of false-positive and false-negative results, and this
holds true for clinical monitoring as well. This was high-
lighted in a separate article in the same April issue of
Plastic and Reconstructive Surgery,2 of which we were also
authors, which demonstrated that clinical monitoring is
indeed associated with false-positives and false-negatives,
and that other monitoring techniques should be evalu-
ated in the context of this. These figures are simply the
statistical outcomes of any screening test, and although
certainly these should be quoted in any study of a mon-
itoring technique, they are not complications.
In terms of the remainder of the questions raised:
1. Six of the eight buried flaps were included in the
Journal of Plastic, Reconstructive&Aesthetic Surgery study.
2. Although 121 cases were included in the Journal of
Plastic, Reconstructive & Aesthetic Surgery study, 30 more
cases had been performed by the time of writing the
current study and over 100 more by today.
3. Buried flaps with suspicious Doppler signals are
taken to the operating room, whereas flaps with a
cutaneous paddle are either taken back to the op-
erating room immediately or compared with clini-
cal monitoring findings (surgeon preference).
4. The Traveling Fellowship was a one-off educa-
tional grant to cover transport and accommoda-
tion costs to allow Mr. Iain S. Whitaker to gain
further experience in microsurgical reconstruc-
tion. There were “no strings” attached and this
award has certainly had no impact on the presen-
tation or publication of work. This has been
clearly declared previously.
5. The authors have no competing interests: finan-
cial, editorial, or otherwise.
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A Commentary on Acellular Dermal Matrix in
Preventing Capsule Formation around Implants
in a Primate Model
Sir:
We reviewed with great interest the article by Stumpet al. comparing capsule formation around breast
implants in the presence and absence of AlloDerm (Life-
Cell Corp., Branchburg, N.J.) in primates and concluding
that the use of AlloDerm effectively prevents capsule
formation.1 We wish to bring to your attention several
components of the article that have the potential to un-
dermine the strength of this argument.
In the middle of the article, there is a deviation in the
p value used for significance from 0.05, the originally
designated threshold in the Materials and Methods sec-
tion, to 0.01. This newly set, tighter p value allows the
authors to dismiss the difference between their control
and experimental specimens in myofibroblast staining
intensity at the deep layers, where AlloDerm did not cover
the implant, as insignificant even though the reported p
value for this was 0.0381, while still claiming statistical
significance in the differences at the anterior and lateral
periimplant tissues, where AlloDerm made contact in the
experimental specimens. Clarification of this change in p
value is warranted so that the results may be correctly
evaluated.
Furthermore, the two photographs used in their Fig-
ure 6 to depict the intense myofibroblast staining of the
deep periimplant tissues of both control and experi-
mental specimens appear alarmingly identical based on
the histologic architecture seen. If in fact the two pho-
tographs published are the same, we assume this was
simply an unintentional error, and submit that the
original article would be enhanced if an erratum is
published with the correct set of photographs.
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